@inproceedings{inproceedings, title  = {{609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma}},

 publisher = {{BMJ Publishing Group Ltd}},

 url = {{https://doi.org/10.1136/jitc-2025-sitc2025.0609 }},

 year = {{2025}},

 month = {{11}},

 author = {{Sarker D and Long G and Pinato DJ and Khattak A and Medina T and Karydis I and Middleton GW and Spiliopoulou P and Rohatgi A and Gutierrez M and Daud A et al}},

 doi = {{10.1136/jitc-2025-sitc2025.0609}},

 journal = {{Regular and Young Investigator Award Abstracts}},

 pages = {{A694-A694}},

 note = {{Accessed on 2025/12/22}}}